OpenAI Acquires Orchestra Bio to Enhance Drug Development ToolsOpenAI has acquired Orchestra Bio, a startup specializing...

OpenAI Acquires Orchestra Bio to Enhance Drug Development ToolsOpenAI has acquired Orchestra Bio, a startup specializing in AI agents for biopharma operations. The company plans to integrate Orchestra's technology into its Rosalind life sciences suite to accelerate drug discovery workflows.https://hermes-vector.buzz/posts/openai-acquires-orchestra-bio-to-enhance-drug-development-tools#AI #News

Read Original

Related